UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Burke & Herbert Bank & Trust Co.

Burke & Herbert Bank & Trust Co. cut its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 18.7% during the second quarter, HoldingsChannel.com reports. The fund owned 556 shares of the healthcare conglomerate’s stock after selling 128 shares during the quarter. Burke & Herbert Bank & Trust Co.’s holdings in UnitedHealth Group were worth $283,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Legend Financial Advisors Inc. lifted its holdings in shares of UnitedHealth Group by 27.4% in the fourth quarter. Legend Financial Advisors Inc. now owns 93 shares of the healthcare conglomerate’s stock valued at $49,000 after purchasing an additional 20 shares in the last quarter. Veracity Capital LLC grew its stake in UnitedHealth Group by 1.5% during the 1st quarter. Veracity Capital LLC now owns 1,335 shares of the healthcare conglomerate’s stock valued at $660,000 after acquiring an additional 20 shares in the last quarter. Rodgers Brothers Inc. lifted its position in shares of UnitedHealth Group by 2.4% in the first quarter. Rodgers Brothers Inc. now owns 842 shares of the healthcare conglomerate’s stock worth $417,000 after purchasing an additional 20 shares in the last quarter. Aprio Wealth Management LLC increased its stake in UnitedHealth Group by 2.1% in the 2nd quarter. Aprio Wealth Management LLC now owns 975 shares of the healthcare conglomerate’s stock valued at $497,000 after buying an additional 20 shares during the period. Finally, Dougherty Wealth Advisers LLC grew its holdings in shares of UnitedHealth Group by 3.9% during the 2nd quarter. Dougherty Wealth Advisers LLC now owns 538 shares of the healthcare conglomerate’s stock valued at $274,000 after acquiring an additional 20 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

UnitedHealth Group stock opened at $574.24 on Wednesday. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $591.54. The stock has a 50-day simple moving average of $524.56 and a 200 day simple moving average of $505.89. The company has a quick ratio of 0.85, a current ratio of 0.88 and a debt-to-equity ratio of 0.67. The stock has a market capitalization of $528.52 billion, a price-to-earnings ratio of 35.10, a P/E/G ratio of 1.56 and a beta of 0.59.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, beating the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The business had revenue of $98.86 billion for the quarter, compared to analysts’ expectations of $98.73 billion. During the same period in the prior year, the firm earned $6.14 earnings per share. UnitedHealth Group’s revenue was up 6.4% compared to the same quarter last year. On average, research analysts anticipate that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 24th. Investors of record on Monday, September 16th will be given a $2.10 dividend. The ex-dividend date of this dividend is Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a yield of 1.46%. UnitedHealth Group’s payout ratio is 51.34%.

Analyst Ratings Changes

A number of research analysts have commented on the company. Piper Sandler boosted their target price on UnitedHealth Group from $566.00 to $571.00 and gave the company an “overweight” rating in a research note on Wednesday, April 17th. TD Cowen upped their target price on UnitedHealth Group from $546.00 to $601.00 and gave the stock a “buy” rating in a research report on Wednesday, July 17th. UBS Group raised their price objective on shares of UnitedHealth Group from $640.00 to $680.00 and gave the stock a “buy” rating in a report on Thursday, July 18th. JPMorgan Chase & Co. increased their price target on shares of UnitedHealth Group from $546.00 to $559.00 and gave the stock an “overweight” rating in a research report on Thursday, May 30th. Finally, Morgan Stanley upped their price objective on UnitedHealth Group from $595.00 to $615.00 and gave the company an “overweight” rating in a research note on Wednesday, July 17th. One equities research analyst has rated the stock with a hold rating, nineteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Buy” and a consensus price target of $614.17.

Insider Activity

In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the transaction, the chief accounting officer now owns 29,501 shares in the company, valued at $16,812,029.88. The sale was disclosed in a document filed with the SEC, which is available through this link. In other news, CAO Thomas E. Roos sold 2,851 shares of the business’s stock in a transaction on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction dated Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the transaction, the executive vice president now owns 7,785 shares in the company, valued at $4,507,748.55. The disclosure for this sale can be found here. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.